COVID-19 Video Series
MPE is developing a COVID-19 video series to gather information from top experts on how COVID-19 is affecting myeloma and AL amyloidosis treatment and clinical trials. Hear from experts how different countries and hospitals are managing the COVID-19 crisis:

Covid video series | Covid-19 vaccine for myeloma patients: risk and recommendations
Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, explains for Myeloma Patients Europe (MPE) the risk and recommendations of the COVID-19 vaccine for myeloma and AL amyloidosis patients.







Covid video series | Covid-19 vaccine for myeloma patients: risk and recommendations
Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, explains for Myeloma Patients Europe (MPE) the risk and recommendations of the COVID-19 vaccine for myeloma and AL amyloidosis patients.







Covid video series | Covid-19 vaccine for myeloma patients: risk and recommendations
Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, explains for Myeloma Patients Europe (MPE) the risk and recommendations of the COVID-19 vaccine for myeloma and AL amyloidosis patients.







Covid video series | Covid-19 vaccine for myeloma patients: risk and recommendations
Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, explains for Myeloma Patients Europe (MPE) the risk and recommendations of the COVID-19 vaccine for myeloma and AL amyloidosis patients.







Covid video series | Covid-19 vaccine for myeloma patients: risk and recommendations
Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, explains for Myeloma Patients Europe (MPE) the risk and recommendations of the COVID-19 vaccine for myeloma and AL amyloidosis patients.







Covid video series | Covid-19 vaccine for myeloma patients: risk and recommendations
Dr Hermann Einsele, Director of the Department of Internal Medicine II at the Würzburg University Hospital, Germany, explains for Myeloma Patients Europe (MPE) the risk and recommendations of the COVID-19 vaccine for myeloma and AL amyloidosis patients.
Subscribe to
our newsletter!